
Mental Health-Sleep Overlap Market Report 2026
Global Outlook – By Treatment And Service Mix (Psychiatric Pharmacotherapy With Sleep Impact, Cognitive Behavioral Therapy (CBT-I) + Cognitive Behavioral Therapy (CBT) Integrated Programs, Tele-Psychiatry Or Therapy Services, Digital Monitoring And Relapse Prevention Tools, Adjunct Devices), By Age Group (Pediatric, Adult, Geriatric), By Delivery Mode (Mobile Applications, Web-Based Platforms, Telehealth Integrations), By Application (Preventive Healthcare And Wellness, Clinical Treatment And Disease Management, Long-Term Care And Assisted Living), By End User Or Channel (Outpatient Mental Health Clinics, Telehealth Platforms, Hospitals Or Behavioral Health Centers, Employer Or Payer Programs, Other End Users) – Market Size, Trends, Strategies, and Forecast to 2035
Mental Health-Sleep Overlap Market Overview
• Mental Health-Sleep Overlap market size has reached to $5.2 billion in 2025 • Expected to grow to $8.44 billion in 2030 at a compound annual growth rate (CAGR) of 10.2% • Growth Driver: Rising Prevalence Of Stress Related Disorders Driving The Market Growth Due To Increasing Sleep Disruptions And Mental Strain • Market Trend: Innovative AI Solutions Enhancing Personalized Mental Health Care And Sleep Support Around The Clock • Asia-Pacific was the largest region and fastest growing region.What Is Covered Under Mental Health-Sleep Overlap Market?
Mental health-sleep overlap refers to the strong, bidirectional relationship between sleep and mental health, where sleep quality, duration, and patterns both influence and are influenced by psychological well-being. This overlap highlights shared biological, psychological, and behavioral mechanisms and underscores the importance of addressing sleep as a core component of mental health assessment, prevention, and treatment. The main treatment and service mixes of mental health-sleep overlap include psychiatric pharmacotherapy with sleep impact, cognitive behavioral therapy (CBT-I) + cognitive behavioral therapy (CBT) integrated programs, tele-psychiatry or therapy services, digital monitoring and relapse prevention tools, and adjunct devices. Psychiatric pharmacotherapy with sleep impact refers to medications prescribed to manage mental health conditions while addressing sleep disturbances. The age groups include pediatric, adult, and geriatric with delivery modes including mobile applications, web-based platforms, and telehealth integrations. The key applications of preventive healthcare and wellness, clinical treatment and disease management, and long-term care and assisted living, while the end-use or channels include outpatient mental health clinics, telehealth platforms, hospitals or behavioral health centers, employer or payer programs, and other end users.
What Is The Mental Health-Sleep Overlap Market Size and Share 2026?
The mental health-sleep overlap market size has grown strongly in recent years. It will grow from $5.2 billion in 2025 to $5.72 billion in 2026 at a compound annual growth rate (CAGR) of 10.0%. The growth in the historic period can be attributed to rising prevalence of anxiety and depression disorders, increasing awareness of sleep disorders, expansion of behavioral therapy adoption, growth in telehealth mental health services, increasing research on sleep and circadian rhythm science.What Is The Mental Health-Sleep Overlap Market Growth Forecast?
The mental health-sleep overlap market size is expected to see rapid growth in the next few years. It will grow to $8.44 billion in 2030 at a compound annual growth rate (CAGR) of 10.2%. The growth in the forecast period can be attributed to growing adoption of personalized sleep-mental health treatment plans, increasing use of AI-driven behavioral analytics, rising employer investment in mental wellness programs, expansion of remote patient monitoring technologies, increasing integration of sleep biomarkers in psychiatric care. Major trends in the forecast period include increasing integration of sleep assessment in mental health screening, rising adoption of integrated CBT-I and CBT treatment programs, growing demand for digital sleep and mood monitoring tools, expansion of tele-psychiatry services addressing sleep disorders, rising focus on preventive mental health and sleep wellness programs.Global Mental Health-Sleep Overlap Market Segmentation
1) By Treatment And Service Mix: Psychiatric Pharmacotherapy With Sleep Impact, Cognitive Behavioral Therapy (CBT-I) + Cognitive Behavioral Therapy (CBT) Integrated Programs, Tele-Psychiatry Or Therapy Services, Digital Monitoring And Relapse Prevention Tools, Adjunct Devices 2) By Age Group: Pediatric, Adult, Geriatric 3) By Delivery Mode: Mobile Applications, Web-Based Platforms, Telehealth Integrations 4) By Application: Preventive Healthcare And Wellness, Clinical Treatment And Disease Management, Long-Term Care And Assisted Living 5) By End User Or Channel: Outpatient Mental Health Clinics, Telehealth Platforms, Hospitals Or Behavioral Health Centers, Employer Or Payer Programs, Other End Users Subsegments: 1) By Psychiatric Pharmacotherapy With Sleep Impact: Antidepressant Medications, Anxiolytic Medications, Mood Stabilizing Agents, Atypical Antipsychotic Medications, Sedative Hypnotic Medications 2) By Cognitive Behavioral Therapy (CBT-I) + Cognitive Behavioral Therapy (CBT) Integrated Programs: Sleep Restriction Therapy Programs, Stimulus Control Therapy Programs, Cognitive Restructuring Therapy, Relaxation Training Programs, Mindfulness-Based Behavioral Therapy 3) By Tele-Psychiatry Or Therapy Services: Video Consultation Services, Audio-Based Therapy Sessions, Text-Based Counseling Platforms, Remote Psychological Assessment Services, Virtual Group Therapy Programs 4) By Digital Monitoring And Relapse Prevention Tools: Sleep Pattern Tracking Software, Mood Monitoring Applications, Behavioral Analytics Platforms, Predictive Risk Assessment Tools, Remote Patient Monitoring Dashboards 5) By Adjunct Devices: Light Therapy Lamps, Smart Sleep Tracking Watches, Biometric Monitoring Bands, Heart Rate Variability Sensors, Circadian Rhythm Regulation DevicesWhat Is The Driver Of The Mental Health-Sleep Overlap Market?
The rising prevalence of stress-related disorders is expected to propel the growth of the mental health–sleep overlap market going forward. Stress-related disorders are conditions in which prolonged exposure to psychological or environmental stressors contributes to symptoms such as anxiety, depression, emotional dysregulation, and impaired daily functioning. The prevalence of these disorders is increasing due to sustained exposure to chronic psychosocial stressors, including work pressures, financial strain, social challenges, and lifestyle changes that overwhelm individual coping mechanisms and negatively affect mental well-being. Stress-related disorders are closely linked to sleep disturbances, as chronic stress disrupts neurobiological processes involved in mood regulation and circadian rhythms, leading to conditions such as Insomnia, fragmented sleep, or hypersomnia. For instance, in May 2024, according to the 2024 annual mental health poll conducted by the American Psychiatric Association, a US-based organization, in 2024, 43% of adults report feeling more anxious than the previous year, up from 37% in 2023 and 32% in 2022. Therefore, the rising prevalence of stress related disorders is driving the growth of the mental health sleep overlap market.Key Players In The Global Mental Health-Sleep Overlap Market
Major companies operating in the mental health-sleep overlap market are Johnson & Johnson, Koninklijke Philips N.V., Teladoc Health, Lyra Health Inc., Headspace Health Inc., Included Health Inc., Talkspace Inc., Spring Health, Whoop Inc., Transcarent Inc., Calm.com Inc., Modern Health Inc., Unmind Ltd., Big Health Inc., Click Therapeutics Inc., Welldoc Inc., Quartet Health Inc., Meru Health Inc., Ieso Digital Health Ltd., Wysa LTD., Oura Health Oy.Global Mental Health-Sleep Overlap Market Trends and Insights
Major companies operating in the mental health-sleep overlap market are focusing on developing innovative solutions such as, artificial intelligence (AI)-powered mental health platforms to provide personalized, 24/7 support for stress and sleep-related issues. Artificial intelligence (AI)-powered mental health platforms are digital tools that use AI to deliver personalized mental health support, such as real-time guidance, coping strategies, and symptom monitoring, helping users manage stress, improve sleep, and access care anytime without waiting for in-person sessions. For instance, in October 2025, Lyra Health, a US-based digital mental health company, launched Lyra AI, a clinical-grade AI platform designed to provide personalized mental health support. Lyra AI integrates advanced conversational AI with the existing Lyra Empower platform to deliver 24/7 guidance for challenges like stress, burnout, and sleep disturbances. The platform combines digital skill-building exercises with live provider sessions, features a risk-flagging system that escalates urgent cases to human clinicians, and adheres to strict clinical and ethical standards through its Polaris Principles. Its applications include improving sleep quality, reducing stress, and supporting overall mental wellness, offering scalable, evidence-based care while maintaining human oversight.What Are Latest Mergers And Acquisitions In The Mental Health-Sleep Overlap Market?
In May 2025, Lofta Inc., a US-based digital health company, partnered with Bloom Mental Health LLC, to integrate sleep apnea monitoring with mental health care solutions. With this partnership, Lofta, Inc. and Bloom Mental Health, LLC aim to provide patients with comprehensive care by tracking sleep patterns, improving early intervention for mental health issues linked to sleep disorders, and enhancing overall patient outcomes. Bloom Mental Health LLC is a US-based digital mental health startup that specializes in providing services addressing the mental health-sleep overlap.Regional Insights
North America was the largest region in the mental health-sleep overlap market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.What Defines the Mental Health-Sleep Overlap Market?
The mental health-sleep overlap market includes revenues earned by entities by providing services such as sleep therapy and counseling, cognitive behavioral therapy for insomnia (CBT-I), mental health therapy and counseling, stress management programs, sleep monitoring and coaching, digital health apps targeting sleep and mental well-being. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.What Key Data And Analysis Are Included In The Mental Health-Sleep Overlap Market Report 2026?
The mental health-sleep overlap market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the mental health-sleep overlap industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Mental Health-Sleep Overlap Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $5.72 billion |
| Revenue Forecast In 2035 | $8.44 billion |
| Growth Rate | CAGR of 10.0% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Treatment And Service Mix, Age Group, Delivery Mode, Application, End User Or Channel |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain. |
| Key Companies Profiled | Johnson & Johnson, Koninklijke Philips N.V., Teladoc Health, Lyra Health Inc., Headspace Health Inc., Included Health Inc., Talkspace Inc., Spring Health, Whoop Inc., Transcarent Inc., Calm.com Inc., Modern Health Inc., Unmind Ltd., Big Health Inc., Click Therapeutics Inc., Welldoc Inc., Quartet Health Inc., Meru Health Inc., Ieso Digital Health Ltd., Wysa LTD., Oura Health Oy. |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
